Personal information

Other IDs

ResearcherID: K-5127-2016
Scopus Author ID: 57090700900

Countries

Czech Republic

Activities

Collapse all

Employment (2)

General University Hospital in Prague: Prague, CZ

2015-05-18 to present (Institute of Biology and Medical Genetics)
Employment
Source: Self-asserted source
Marianna Borecká

Charles University: Prague, CZ

2013 to present (First Faculty of Medicine)
Employment
Source: Self-asserted source
Marianna Borecká

Education and qualifications (2)

Charles University: Prague, CZ

2012 to 2020-11-30 | Ph.D. (First Faculty of Medicine)
Education
Source: Self-asserted source
Marianna Borecká

Charles University: Prague, CZ

2011 | M.Sc. (Fakulty of Science)
Education
Source: Self-asserted source
Marianna Borecká

Works (16)

Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer

Cancers
2020-04 | Journal article | Author
DOI: 10.3390/cancers12040956
Contributors: Klara Lhotova; Lenka Stolarova; Petra Zemankova; Michal Vocka; Marketa Janatova; Marianna Borecká; Marta Cerna; Sandra Jelinkova; Jan Kral; Zuzana Volkova et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Truncated PPM1D impairs stem cell response to genotoxic stress and promotes growth of APC-deficient tumors in the mouse colon.

Cell death & disease
2019-10-28 | Journal article
DOI: 10.1038/s41419-019-2057-4
PMID: 31659152
PMC: PMC6817818
Source: Self-asserted source
Marianna Borecká

Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers.

Cancers
2019-05-28 | Journal article
DOI: 10.3390/cancers11060738
PMID: 31141992
PMC: PMC6627684
Source: Self-asserted source
Marianna Borecká

Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer.

International journal of cancer
2019-05-20 | Journal article
DOI: 10.1002/ijc.32385
PMID: 31050813
Source: Self-asserted source
Marianna Borecká

Genetic analysis of subsequent second primary malignant neoplasms in long-term pancreatic cancer survivors suggests new potential hereditary genetic alterations

2019-01 | Journal article
DOI: 10.2147/cmar.s185352
Part of ISSN: 1179-1322
Source: Self-asserted source
Marianna Borecká

Contribution of Massive Parallel Sequencing to Diagnosis of Hereditary Ovarian Cancer in the Czech Republic.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
2019-01-01 | Journal article
DOI: 10.14735/amko2019s72
PMID: 31409082
Source: Self-asserted source
Marianna Borecká

Germline CHEK2 Gene Mutations in Hereditary Breast Cancer Predisposition - Mutation Types and their Biological and Clinical Relevance.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
2019-01-01 | Journal article
DOI: 10.14735/amko2019s36
PMID: 31409080
Source: Self-asserted source
Marianna Borecká

Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes

PLoS ONE
2018 | Journal article
DOI: 10.1371/journal.pone.0195761
EID:

2-s2.0-85045440072
Contributors: Soukupova, J.; Zemankova, P.; Lhotova, K.; Janatova, M.; Borecka, M.; Stolarova, L.; Lhota, F.; Foretova, L.; Machackova, E.; Stranecky, V. et al.
Source: Self-asserted source
Marianna Borecká via Scopus - Elsevier

BRCA1 and BRCA2 5′ noncoding region variants identified in breast cancer patients alter promoter activity and protein binding

2018-12 | Journal article
DOI: 10.1002/humu.23652
Part of ISSN: 1059-7794
Source: Self-asserted source
Marianna Borecká

Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic

Cancer Genetics
2016 | Journal article
DOI: 10.1016/j.cancergen.2016.03.003
WOSUID:

WOS:000389160300004
Contributors: Borecka, M.; Zemankova, P.; Vocka, M.; Soucek, P.; Soukupova, J.; Kleiblova, P.; Sevcik, J.; Kleibl, Z.; Janatova, M.
Source: Self-asserted source
Marianna Borecká via ResearcherID
grade
Preferred source (of 2)‎

PALB2 as another candidate gene for genetic testing in patients with hereditary breast cancer in Czech Republic,PALB2 jako další kandidátní gen pro genetické testování u pacientů s hereditárním karcinomem prsu v České republice

Klinicka Onkologie
2016 | Journal article
DOI: 10.14735/amko2016S31
EID:

2-s2.0-84956675464
Contributors: Janatová, M.; Borecká, M.; Soukupová, J.; Kleiblová, P.; Stříbrná, J.; Vočka, M.; Zemánková, P.; Panczak, A.; Veselá, K.; Souček, P. et al.
Source: Self-asserted source
Marianna Borecká via Scopus - Elsevier

The c.657de15 variant in the NBN gene predisposes to pancreatic cancer

Gene
2016 | Journal article
DOI: 10.1016/j.gene.2016.04.056
WOSUID:

WOS:000377827600008
Contributors: Borecka, M.; Zemankova, P.; Lhota, F.; Soukupova, J.; Kleiblova, P.; Vocka, M.; Soucek, P.; Ticha, I.; Kleibl, Z.; Janatova, M.
Source: Self-asserted source
Marianna Borecká via ResearcherID
grade
Preferred source (of 2)‎

Characterization of breast cancer (BC) predisposition variants in high risk BRCA1-and BRCA2-negative BC patients using panel next-gen sequencing

European Journal of Cancer
2014 | Journal article
WOSUID:

WOS:000351589702140
Contributors: Lhota, F.; Boudova, P.; Stranecky, V.; Soukupova, J.; Kleiblova, P.; Hojny, J.; Janatova, M.; Borecka, M.; Pohlreich, P.; Kleibl, Z.
Source: Self-asserted source
Marianna Borecká via ResearcherID

Hereditary variants of genes coding for TP53 and its regulators (CHK2 and WIP1) in high-risk breast cancer patients

European Journal of Cancer
2014 | Journal article
WOSUID:

WOS:000351589702142
Contributors: Kleiblova, P.; Hojny, J.; Lhota, F.; Macurek, L.; Soukupova, J.; Janatova, M.; Boudova, P.; Borecka, M.; Pohlreich, P.; Kleibl, Z.
Source: Self-asserted source
Marianna Borecká via ResearcherID

Identification and quantification of BRCA1 splicing variants

European Journal of Cancer
2014 | Journal article
WOSUID:

WOS:000351589700286
Contributors: Lhota, F.; Hojny, J.; Kleiblova, P.; Sevcik, J.; Soukupova, J.; Janatova, M.; Boudova, P.; Borecka, M.; Pohlreich, P.; Kleibl, Z.
Source: Self-asserted source
Marianna Borecká via ResearcherID

Identification of pathogenic mutations in RAD51 paralogs in BRCA1/2-negative ovarian cancer patients in the Czech Republic

European Journal of Cancer
2014 | Journal article
WOSUID:

WOS:000351589702134
Contributors: Janatova, M.; Soukupova, J.; Kleibl, Z.; Kleiblova, P.; Lhota, F.; Hojny, J.; Borecka, M.; Boudova, P.; Pohlreich, P.
Source: Self-asserted source
Marianna Borecká via ResearcherID
How many people are using ORCID?